First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Announces Quarterly Dividend of $0.09

Posted by Don Miller on Jun 25th, 2026

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) declared a quarterly dividend on Wednesday, June 24th, NASDAQ Dividends reports. Stockholders of record on Thursday, June 25th will be paid a dividend of 0.092 per share on Tuesday, June 30th. This represents a c) annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Thursday, June 25th. This is a 60.6% increase from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of NASDAQ:FTXH traded up $0.34 during trading on Thursday, reaching $37.12. 2,522 shares of the stock traded hands, compared to its average volume of 7,698. The stock has a 50-day moving average of $34.71 and a two-hundred day moving average of $34.18. First Trust Nasdaq Pharmaceuticals ETF has a 52-week low of $25.58 and a 52-week high of $37.60. The stock has a market cap of $33.41 million, a P/E ratio of 14.51 and a beta of 0.47.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

Institutional investors have recently added to or reduced their stakes in the business. NBC Securities Inc. raised its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 33.0% in the fourth quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock worth $44,000 after purchasing an additional 329 shares during the last quarter. Kestra Advisory Services LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter valued at about $59,000. Raymond James Financial Inc. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter valued at about $57,000. Flagship Harbor Advisors LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter valued at about $205,000. Finally, Flputnam Investment Management Co. bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the fourth quarter worth approximately $230,000.

About First Trust Nasdaq Pharmaceuticals ETF

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.